Open AccessA novel intergenic region ALK fusion is targetable by alectinib in a non-small cell lung cancer patient with brain metastasis
Author(s) -
Wei Cheng,
Chunfa Qian,
Haitao Zhang,
Qiang Meng,
Jiani C. Yin,
Shencun Fang
Publication year - 2022
Publication title -
anti-cancer drugs
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.651
H-Index - 93
eISSN - 1473-5741
pISSN - 0959-4973
DOI - 10.1097/cad.0000000000001363
Subject(s) - alectinib , anaplastic lymphoma kinase , crizotinib , cancer research , lung cancer , rna , biology , fusion gene , targeted therapy , brain metastasis , cancer , metastasis , gene , medicine , oncology , genetics , malignant pleural effusion